Sue Casey

Sue Casey, RN, CCRC

Program Manager, Joseph F. Novogratz Family Heart Rhythm Center

Sue currently oversees the Minneapolis Heart Institute Foundation heart rhythm investigator-initiated research study portfolio, with a focus on supporting the center’s vision of improving the lives of heart rhythm patients. She joined the MHIF team in 1992 as manager of the Hypertrophic Cardiomyopathy Clinic, with an interest in genetic arrhythmias and electrophysiology. As a registered nurse, Sue has over 25 years of cardiology research experience and certification as a clinical research coordinator (CCRC) by the Association of Clinical Research Professionals.

Since joining the team, Sue has contributed to more than 50 peer-reviewed publications, several of which have changed the way patients with a specific genetic heart disease were diagnosed and treated. She’s also managed several national and international multi-institutional studies.

Back to Heart Rhythm Team

Sue Casey
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.